IO Biotech Inc Sustainability Reports
IO Biotech, Inc. is a clinical-stage biopharmaceutical company focused on developing disruptive immune-modulating cancer vaccines.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG0131XRYY7
4 reports from 2021 to 2024
Company Profile
IO Biotech, Inc. is a clinical-stage biopharmaceutical company focused on developing disruptive immune-modulating cancer vaccines.
Reports
4 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
